Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 75 of 99

  1. Ribavirin 200 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  2. Rilonacept

    Regeneron UK Limited

    Autoimmune Neurosensory Hearing Loss (ANSHL)

    phase 1 small molecule active

    1 trial

  3. Risperidone

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  4. Risperidone

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  5. Risperidone

    The First People's Hospital of Lianyungang

    Schizophrenia

    phase 1 small molecule active

    1 trial

  6. Ritonavir Tablet 100mg

    The First People's Hospital of Lianyungang

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  7. Ritonavir for cycle1 and NORVIR for cycle 2

    The First People's Hospital of Lianyungang

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  8. Rituximab

    The First People's Hospital of Lianyungang

    Diffuse Large B-cell Lymphoma Recurrent

    phase 1 small molecule active

    1 trial

  9. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Carcinoma

    phase 1 small molecule completed

    1 trial

  10. Roflumilast

    Takeda

    Schizophrenia

    phase 1 small molecule completed

    1 trial

  11. Rongliflozin

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  12. Ropinirole HCl 0.25 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  13. Rose bengal disodium

    PROVECTUS BIOPHARMACEUTICALS, INC.

    Neuroendocrine Tumors Metastatic to the Liver

    phase 1 small molecule active

    1 trial

  14. Rowasa® 4 gm/60 mL Rectal Enema

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  15. Rugonersen

    Hoffmann-La Roche

    Angelman Syndrome (AS)

    phase 1 small molecule active

    1 trial

  16. S 55746

    Servier Laboratories (Aust.) Pty.

    Chronic Lymphocytic Leukaemia (CLL)

    phase 1 small molecule completed

    1 trial

  17. S005183-297

    The George Institute

    No medical condition.

    phase 1 other active

    1 trial

  18. S005183-303

    The George Institute

    No medical condition.

    phase 1 other active

    1 trial

  19. S005190-203

    The George Institute

    No medical condition.

    phase 1 other active

    1 trial

  20. S005190-204

    The George Institute

    No medical condition.

    phase 1 other active

    1 trial

  21. S005190-205

    The George Institute

    No medical condition.

    phase 1 other active

    1 trial

  22. S005190-206

    The George Institute

    No medical condicion.

    phase 1 other active

    1 trial

  23. S005190-213

    The George Institute

    No medical condicion.

    phase 1 other active

    1 trial

  24. S095031-218

    The George Institute

    Newly diagnosed and/or previously treated IDH1-mutated malignancies

    phase 1 other active

    1 trial

  25. S221237-176

    The George Institute

    No medical condition

    phase 1 other active

    1 trial

  26. SA55 Injection

    Sinovac Research and Development Co.,

    COVID-19

    phase 1 small molecule active

    1 trial

  27. SA55 nasal spray

    Sinovac Research and Development Co.,

    COVID-19

    phase 1 small molecule active

    1 trial

  28. SAB-176

    SAB Biotherapeutics

    Influenza Type A

    phase 1 mab completed

    1 trial

  29. SAB-185

    SAB Biotherapeutics

    COVID-19

    phase 1 mab active

    2 trials

  30. SAB-301

    SAB Biotherapeutics

    Middle East Respiratory Syndrome Coronavirus

    phase 1 mab completed

    1 trial

  31. SAD18184/MAD18185

    Sanofi-aventis Healthcare Pty Ltd

    Asthma

    phase 1 other active

    1 trial

  32. SAD18258

    Sanofi-aventis Healthcare Pty Ltd

    Osteoarthritis

    phase 1 other active

    1 trial

  33. SAD18615-MAD18616

    Sanofi-aventis Healthcare Pty Ltd

    Dermatitis atopic

    phase 1 other active

    1 trial

  34. SAGE-718

    SUPERNUS PHARMACEUTICALS, INC.

    Healthy Volunteer

    phase 1 small molecule completed

    3 trials

  35. SAGE-904

    SUPERNUS PHARMACEUTICALS, INC.

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  36. SAM-315

    Wyeth is now a wholly owned subsidiary of Pfizer

    Alzheimer Disease

    phase 1 small molecule completed

    1 trial

  37. SAR231893 (REGN668)

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  38. SAR231893 (REGN668) DP1

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  39. SAR441000

    Atrium Therapeutics

    Metastatic Neoplasm

    phase 1 small molecule terminated

    1 trial

  40. SAR447971 first-in-human study

    Sanofi-aventis Healthcare Pty Ltd

    Hidradenitis

    phase 1 other active

    1 trial

  41. SAR448501

    Sanofi Pasteur

    B-cell Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  42. SB-659032

    GlaxoSmithKline

    Atherosclerosis

    phase 1 small molecule completed

    1 trial

  43. SB-728-T

    SANGAMO THERAPEUTICS, INC

    HIV Infection

    phase 1 gene therapy completed

    1 trial

  44. SB-728mR-HSPC Infusion 3 days following busulfan conditioning

    SANGAMO THERAPEUTICS, INC

    HIV

    phase 1 gene therapy active

    1 trial

  45. SB-FIX

    SANGAMO THERAPEUTICS, INC

    Hemophilia B

    phase 1 mab terminated

    1 trial

  46. SB27-1005

    Samsung Bioepis NL B.V.

    Non-small cell lung cancer

    phase 1 other active

    1 trial

  47. SBP-9330

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 1 small molecule completed

    1 trial

  48. SC HYLENEX and Ceftriaxone

    HALOZYME THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.